HER2-positive Breast Cancer Clinical Trials in Dijon
2 recruitingDijon, France
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
HER2-positive Breast CancerHER2 + Breast CancerHER2 Mutation-Related Tumors+10 more
Iambic Therapeutics, Inc243 enrolled45 locationsNCT06253871
Recruiting
Phase 2
Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
HER2-positive Breast Cancer
Institut Curie66 enrolled13 locationsNCT05955170